Reviewed,
UniProtKB/Swiss-Prot O00559 (RCAS1_HUMAN)
Last modified
October 13, 2009.
Version 85.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Receptor-binding cancer antigen expressed on SiSo cells Alternative name(s): Cancer-associated surface antigen RCAS1 Estrogen receptor-binding fragment-associated gene 9 protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 213 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. Ref.7 |
| Subunit structure | Homodimer. |
| Subcellular location | Golgi apparatus membrane; Single-pass type III membrane protein. Note: According to Ref.1, it also exists as a soluble form which has the same biological activities. The existence of such soluble form is however uncertain. Ref.7 |
| Tissue specificity | Widely expressed. Expressed in ovary, testis, prostate, thymus, muscle and heart, but not in small intestine, colon, lymph nodes, or peripherical blood lymphocytes. The protein is not detected in any of the above organs. |
| Induction | By estrogen. |
| Domain | The coiled coil domain is necessary for the homodimerization. |
| Involvement in disease | Defects in EBAG9 may be a cause of breast cancers and adenocarcinomas of the lung. It is present and overexpressed in many patients suffering from breast carcinomas, its level of expression correlates with tumor grade, suggesting that it may be involved in cancer immune escape. According to Ref.7, it is however not directly a tumor-associated antigen, but it rather modulates surface expression of tumor-associated O-linked glycan Tn when it is overexpressed, suggesting that it contributes indirectly to the antigenicity of tumor cells. Ref.5 Ref.6 |
| Miscellaneous | May serve as a prognostic marker for cancers such as adenocarcinomas of the lung and breast cancers. |
| Caution | It was initially reported to be a ligand for some putative receptor present on T-, B-, natural killer (NK) cells and various human cell lines. However, Ref.7 showed that it does not bind any receptor. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Apoptosis |
| Cellular component | Golgi apparatus Membrane |
| Domain | Coiled coil Signal-anchor Transmembrane |
| PTM | Phosphoprotein |
| Technical term | Complete proteome |
| Gene Ontology (GO) | |
| Biological process | apoptosis Inferred from electronic annotation. Source: UniProtKB-KW regulation of cell growth Ref.1Non-traceable author statement. Source: UniProtKB |
| Cellular component | Golgi apparatus Inferred from direct assay. Source: HPA focal adhesionInferred from direct assay. Source: HPA integral to membraneNon-traceable author statement. Source: UniProtKB soluble fractionNon-traceable author statement. Source: UniProtKB |
| Molecular function | apoptotic protease activator activity Ref.1 Non-traceable author statement. Source: UniProtKB |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 213 | 213 | Receptor-binding cancer antigen expressed on SiSo cells | PRO_0000097195 | |||||
Regions | |||||||||
| Topological domain | 1 – 6 | 6 | Extracellular Potential | ||||||
| Transmembrane | 7 – 27 | 21 | Signal-anchor for type III membrane protein Potential | ||||||
| Topological domain | 28 – 213 | 186 | Cytoplasmic Potential | ||||||
| Coiled coil | 163 – 211 | 49 | Potential | ||||||
| Compositional bias | 160 – 163 | 4 | Poly-Glu | ||||||
Amino acid modifications | |||||||||
| Modified residue | 36 | 1 | Phosphoserine Ref.8 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 | ||||||
| Modified residue | 41 | 1 | Phosphothreonine Ref.8 | ||||||
| Modified residue | 48 | 1 | Phosphotyrosine Ref.8 | ||||||
| Modified residue | 94 | 1 | Phosphotyrosine Ref.9 | ||||||
Experimental info | |||||||||
| Sequence conflict | 183 | 1 | K → E in AAH05249. Ref.4 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1." Nakashima M., Sonoda K., Watanabe T. Nat. Med. 5:938-942(1999) [PubMed: 10426319] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Uterine adenocarcinoma. |
| [2] | "Isolation of estrogen-responsive genes with a CpG island library." Watanabe T., Inoue S., Hiroi H., Orimo A., Kawashima H., Muramatsu M. Mol. Cell. Biol. 18:442-449(1998) [PubMed: 9418891] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Mammary cancer. |
| [3] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain, Lung and Placenta. |
| [5] | "RCAS1 is associated with ductal breast cancer progression." Rousseau J., Tetu B., Caron D., Malenfant P., Cattaruzzi P., Audette M., Doillon C., Tremblay J.P., Guerette B. Biochem. Biophys. Res. Commun. 293:1544-1549(2002) [PubMed: 12054692] [Abstract] Cited for: DISEASE. |
| [6] | "RCAS1 expression: a potential prognostic marker for adenocarcinomas of the lung." Oizumi S., Yamazaki K., Nakashima M., Watanabe T., Hommura F., Ogura S., Nishimura M., Dosaka-Akita H. Oncology 62:333-339(2002) [PubMed: 12138241] [Abstract] Cited for: DISEASE. |
| [7] | "The Golgi protein RCAS1 controls cell surface expression of tumor-associated O-linked glycan antigens." Engelsberg A., Hermosilla R., Karsten U., Schuelein R., Doerken B., Rehm A. J. Biol. Chem. 278:22998-23007(2003) [PubMed: 12672804] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [8] | "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry." Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M., Peters E.C. Anal. Chem. 76:2763-2772(2004) [PubMed: 15144186] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36; THR-41 AND TYR-48, MASS SPECTROMETRY. Tissue: T-cell. |
| [9] | "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells." Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J. Nat. Biotechnol. 23:94-101(2005) [PubMed: 15592455] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-94, MASS SPECTROMETRY. |
| [10] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36, MASS SPECTROMETRY. Tissue: Epithelium. |
| [11] | "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line." Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S. Electrophoresis 28:2027-2034(2007) [PubMed: 17487921] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36, MASS SPECTROMETRY. |
| [12] | "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column." Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y. Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36, MASS SPECTROMETRY. |
| [13] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36, MASS SPECTROMETRY. Tissue: Platelet. |
| [14] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36, MASS SPECTROMETRY. |
| [15] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| AF006265 mRNA. Translation: AAB61617.1. AB007619 mRNA. Translation: BAA22572.1. CR456984 mRNA. Translation: CAG33265.1. BC005249 mRNA. Translation: AAH05249.1. BC017729 mRNA. Translation: AAH17729.1. BC022506 mRNA. Translation: AAH22506.1. | |
| IPI | IPI00299076. |
| RefSeq | NP_004206.1. NP_936056.1. |
| UniGene | Hs.409368 |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | O00559. |
PTM databases | |
| PhosphoSite | O00559. |
Proteomic databases | |
| PRIDE | O00559. |
Genome annotation databases | |
| Ensembl | ENST00000276658; ENSP00000276658; ENSG00000147654; Homo sapiens. [Genome view] ENST00000337573; ENSP00000337675; ENSG00000147654; Homo sapiens. [Genome view] ENST00000395785; ENSP00000379131; ENSG00000147654; Homo sapiens. [Genome view] |
| GeneID | 9166. |
| KEGG | hsa:9166. |
| UCSC | uc003ynf.1. human. |
Organism-specific databases | |
| CTD | 9166. |
| GeneCards | GC08P110621. |
| H-InvDB | HIX0007729. |
| HGNC | HGNC:3123. EBAG9. |
| HPA | HPA021153. HPA021154. |
| MIM | 605772. gene. |
| PharmGKB | PA27581. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOVERGEN | O00559. |
Gene expression databases | |
| ArrayExpress | O00559. |
| Bgee | O00559. |
| CleanEx | HS_EBAG9. |
| Genevestigator | O00559. |
| GermOnline | ENSG00000147654. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR017025. Cancer-assoc_antigen_RCAS1. [Graphical view] |
| PIRSF | PIRSF034247. RCAS1. 1 hit. |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 34373. |
| SOURCE | Search... |
Entry information
| Entry name | RCAS1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O00559 Secondary accession number(s): Q6IB20, Q9BS76 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 8 Human chromosome 8: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |

Clusters with


